97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

23 trials found

diseases per page:

Showing 1 to 10 of 23 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-005528-39-NL (EUCTR)	14/12/2022	12/09/2022	Efficacy and Safety of Combination Therapy with Guselkumaband Golimumab in Participants with Moderat ...	A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Stud ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: JNJ-78934804 INN or Proposed INN: Guselkumab Other descriptive name: Guselkumab INN or Pr ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	550	Phase 2	Portugal;Taiwan;Hong Kong;Slovakia;Greece;Ukraine;Chile;Italy;India;France;Jordan;Denmark;Latvia;Kor ...
2	JPRN-jRCT2031220308	01/11/2022	01/09/2022	A Study of Combination Therapy with Guselkumaband Golimumab in Participants with Moderately to Sever ...	A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Stud ...	Colitis, Ulcerative	Guselkumab Guselkumabwill be administered as subcutaneous injection. Participants will receive guselku ...	Nishikawa Kazuko	NULL	Pending	>= 18age old	<= 65age old	Both	550	Phase 2	Argentina;Australia;Austria,;Belgium;Bulgaria;Brazil;Canada;Switzerland;Chile;Czechia;Germany;Denmar ...
3	NCT05242484 (ClinicalTrials.gov)	September 19, 2022	15/2/2022	A Study of Combination Therapy With Guselkumaband Golimumab in Participants With Moderately to Sever ...	A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Stud ...	Colitis, Ulcerative	Biological: Guselkumab;Biological: Golimumab;Biological: JNJ-78934804;Drug: Placebo	Janssen Research & Development, LLC	NULL	Recruiting	18 Years	65 Years	All	550	Phase 2	United States;Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;Croatia;Czechia;Denma ...
4	NCT05528510 (ClinicalTrials.gov)	September 13, 2022	19/8/2022	A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis	A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evalua ...	Colitis, Ulcerative	Drug: Guselkumab Dose 1;Drug: Guselkumab Dose 2;Drug: Guselkumab Dose 3;Other: Placebo	Janssen Research & Development, LLC	NULL	Recruiting	18 Years	N/A	All	400	Phase 3	United States;Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;China;Czechia;France;Germany;Hungar ...
5	EUCTR2018-004002-25-SK (EUCTR)	28/05/2021	13/01/2021	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active U ...	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: Guselkumab Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1000	Phase 2;Phase 3	Serbia;Portugal;United States;Taiwan;Slovakia;Spain;Ukraine;Ireland;Russian Federation;Israel;Italy; ...
6	EUCTR2018-004002-25-LV (EUCTR)	27/05/2021	02/02/2021	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active U ...	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: Guselkumab Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	950	Phase 2;Phase 3	Portugal;Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Ireland;Russian Federation;Israel;Italy; ...
7	EUCTR2018-004002-25-AT (EUCTR)	12/05/2021	21/12/2020	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active U ...	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: Guselkumab Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1000	Phase 2;Phase 3	Japan;New Zealand;Sweden;United States;Serbia;Portugal;Taiwan;Slovakia;Spain;Ukraine;Ireland;Russian ...
8	EUCTR2018-004002-25-NL (EUCTR)	06/07/2020	17/09/2019	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active U ...	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: Guselkumab Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1000	Phase 2;Phase 3	Portugal;Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Ireland;Russian Federation;Israel;Italy; ...
9	JPRN-JapicCTI-194980	22/5/2020	30/09/2019	A Study of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Ulcerative Colitis	Intervention name : Guselkumab INN of the intervention : Guselkumab Dosage And administration of the i ...	Janssen Pharmaceutical K.K.	NULL	recruiting	18		BOTH	1000	Phase 2-3	Japan, Asia except Japan, North America, Europe
10	EUCTR2018-004002-25-BG (EUCTR)	13/05/2020	24/02/2020	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active U ...	A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1000	Phase 2;Phase 3	United States;Portugal;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Italy;France;Malaysia ...

First Previous1 2 3Next Last